On November 4, RJH Biosciences Inc. shared the decision made by the Berkeley Skydeck to admit RJH Biosciences into the Fall 2020 Cohort of Berkeley SkyDeck. More than 1800 companies applied for selection to Fall 2020 Cohort and only 16 companies were selected. RJH Biosciences is pleased to be among this select group of companies. The Cohort companies receive a $100,000 investment from the Berkeley SkyDeck Fund and access to 300 top advisors and mentors. RJH Biosciences Inc., a privately held biotech company in Edmonton, Alberta, was recognized for its novel technology that packages nucleic acids iton virus-like particles and enables delivery of nucleic acids to specific types of cells. See the full news release here.